279 related articles for article (PubMed ID: 27016021)
1. 1-Deoxysphingolipid-induced neurotoxicity involves N-methyl-d-aspartate receptor signaling.
Güntert T; Hänggi P; Othman A; Suriyanarayanan S; Sonda S; Zuellig RA; Hornemann T; Ogunshola OO
Neuropharmacology; 2016 Nov; 110(Pt A):211-222. PubMed ID: 27016021
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
3. Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure.
McKay S; Bengtson CP; Bading H; Wyllie DJ; Hardingham GE
Neuropharmacology; 2013 Nov; 74():119-25. PubMed ID: 23402996
[TBL] [Abstract][Full Text] [Related]
4. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals.
Tremblay R; Chakravarthy B; Hewitt K; Tauskela J; Morley P; Atkinson T; Durkin JP
J Neurosci; 2000 Oct; 20(19):7183-92. PubMed ID: 11007874
[TBL] [Abstract][Full Text] [Related]
5. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors.
Gu Y; Genever PG; Skerry TM; Publicover SJ
Calcif Tissue Int; 2002 Mar; 70(3):194-203. PubMed ID: 11907717
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
7. Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.
Wu YN; Johnson SW
Brain Res; 2015 Apr; 1603():1-7. PubMed ID: 25656790
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
9. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs.
Wang X; Ma Z; Fu Z; Gao S; Yang L; Jin Y; Sun H; Wang C; Fan W; Chen L; Zheng QY; Bi G; Ma CL
ASN Neuro; 2016; 8(2):. PubMed ID: 27067428
[TBL] [Abstract][Full Text] [Related]
11. Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures.
Milhaud D; Fagni L; Bockaert J; Lafon-Cazal M
Neuropharmacology; 2000 Sep; 39(12):2244-54. PubMed ID: 10974308
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of N-methyl-D-aspartate receptors increases paraoxon-induced apoptosis in cultured neurons.
Wu X; Tian F; Okagaki P; Marini AM
Toxicol Appl Pharmacol; 2005 Oct; 208(1):57-67. PubMed ID: 16164961
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape.
Fiumelli H; Riederer IM; Martin JL; Riederer BM
Cell Motil Cytoskeleton; 2008 Jun; 65(6):495-504. PubMed ID: 18412220
[TBL] [Abstract][Full Text] [Related]
14. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
Pringle AK; Self J; Eshak M; Iannotti F
Eur J Neurosci; 2000 Nov; 12(11):3833-42. PubMed ID: 11069578
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression.
Schelman WR; Andres R; Ferguson P; Orr B; Kang E; Weyhenmeyer JA
Brain Res Mol Brain Res; 2004 Sep; 128(1):20-9. PubMed ID: 15337314
[TBL] [Abstract][Full Text] [Related]
16. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
[TBL] [Abstract][Full Text] [Related]
17. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
Subramaniam S; Donevan SD; Rogawski MA
J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
[TBL] [Abstract][Full Text] [Related]
18. Pathologically activated neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis(propyl)-cognitin.
Luo J; Li W; Zhao Y; Fu H; Ma DL; Tang J; Li C; Peoples RW; Li F; Wang Q; Huang P; Xia J; Pang Y; Han Y
J Biol Chem; 2010 Jun; 285(26):19947-58. PubMed ID: 20404346
[TBL] [Abstract][Full Text] [Related]
19. Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.
Shin AH; Kim HJ; Thayer SA
Br J Pharmacol; 2012 Jun; 166(3):1002-17. PubMed ID: 22142193
[TBL] [Abstract][Full Text] [Related]
20. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N
J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
